Free Trial

Cushman & Wakefield plc (NYSE:CWK) Shares Acquired by Amundi

Cushman & Wakefield logo with Finance background
Remove Ads

Amundi raised its position in shares of Cushman & Wakefield plc (NYSE:CWK - Free Report) by 191.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 117,774 shares of the company's stock after acquiring an additional 77,415 shares during the period. Amundi owned approximately 0.05% of Cushman & Wakefield worth $1,436,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Vaughan Nelson Investment Management L.P. grew its position in Cushman & Wakefield by 9.6% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 12,474,380 shares of the company's stock valued at $163,164,000 after acquiring an additional 1,094,260 shares during the period. State Street Corp boosted its position in shares of Cushman & Wakefield by 9.8% in the third quarter. State Street Corp now owns 8,463,595 shares of the company's stock worth $115,359,000 after buying an additional 756,966 shares during the period. Geode Capital Management LLC boosted its position in shares of Cushman & Wakefield by 7.5% in the third quarter. Geode Capital Management LLC now owns 5,696,370 shares of the company's stock worth $77,656,000 after buying an additional 395,652 shares during the period. Charles Schwab Investment Management Inc. boosted its position in shares of Cushman & Wakefield by 1.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,027,744 shares of the company's stock worth $52,683,000 after buying an additional 52,178 shares during the period. Finally, Raymond James Financial Inc. purchased a new stake in shares of Cushman & Wakefield in the fourth quarter worth about $25,964,000. Hedge funds and other institutional investors own 95.56% of the company's stock.

Remove Ads

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. upped their target price on Cushman & Wakefield from $14.00 to $17.00 and gave the stock a "neutral" rating in a research report on Monday, December 16th. Citigroup decreased their target price on Cushman & Wakefield from $16.00 to $12.00 and set a "neutral" rating for the company in a research report on Monday, March 17th. Jefferies Financial Group downgraded Cushman & Wakefield from a "buy" rating to a "hold" rating and decreased their target price for the stock from $18.00 to $14.00 in a research report on Thursday, January 2nd. Finally, The Goldman Sachs Group decreased their target price on Cushman & Wakefield from $13.00 to $11.50 and set a "sell" rating for the company in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $14.10.

Get Our Latest Report on Cushman & Wakefield

Cushman & Wakefield Stock Down 1.5 %

CWK traded down $0.16 on Friday, reaching $10.42. The company's stock had a trading volume of 3,997,174 shares, compared to its average volume of 1,945,696. The stock has a market cap of $2.39 billion, a price-to-earnings ratio of 18.94 and a beta of 1.40. Cushman & Wakefield plc has a 1 year low of $9.24 and a 1 year high of $16.11. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.15 and a quick ratio of 1.18. The business's 50 day moving average is $12.37 and its 200 day moving average is $13.19.

Cushman & Wakefield (NYSE:CWK - Get Free Report) last issued its quarterly earnings results on Thursday, February 20th. The company reported $0.48 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.03. The firm had revenue of $2.63 billion during the quarter, compared to the consensus estimate of $2.67 billion. Cushman & Wakefield had a return on equity of 12.62% and a net margin of 1.39%. As a group, research analysts forecast that Cushman & Wakefield plc will post 1.2 EPS for the current fiscal year.

About Cushman & Wakefield

(Free Report)

Cushman & Wakefield Plc engages in the provision of commercial real estate services. It operates through the following geographical segments: Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific (APAC). The Americas segment consists of operations located in the United States, Canada and key markets in Latin America.

Read More

Institutional Ownership by Quarter for Cushman & Wakefield (NYSE:CWK)

Should You Invest $1,000 in Cushman & Wakefield Right Now?

Before you consider Cushman & Wakefield, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cushman & Wakefield wasn't on the list.

While Cushman & Wakefield currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

The Future of Healthcare: 3 AI Stocks Leading the Way

The Future of Healthcare: 3 AI Stocks Leading the Way

2025 promises explosive growth for AI, but which companies are making a difference in healthcare? Chris Markoch highlights three stocks leading the charge.

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads